Sign In
Buy NDAQ
$77.65
-3.96 (-4.85%)
At Close: Jun 25, 2026
Invizyne's Nasdaq IPO Marks New Era of Biomanufacturing
04:05pm, Wednesday, 13'th Nov 2024
Underlying technology demonstrates the use of enhanced enzyme systems outside of cells can bypass many of the limitations associated with traditional cell-based synthetic biology Underlying technology
Horizon Space Acquisition I Corp. Announces Transfer to Nasdaq Capital Market
09:45am, Wednesday, 13'th Nov 2024
NEW YORK, NY / ACCESSWIRE / November 13, 2024 / Horizon Space Acquisition I Corp. (the "Company") (Nasdaq:HSPO), a special purpose acquisition company, today announced that the Nasdaq Stock Market LLC
SaverOne Regains Compliance with Nasdaq Minimum Bid Price Requirement
08:40am, Wednesday, 13'th Nov 2024
Petah Tikvah, Israel, Nov. 13, 2024 (GLOBE NEWSWIRE) -- SaverOne 2014 Ltd. (Nasdaq: SVRE, TASE: SVRE), a technology company that develops and sells advanced transportation safety solutions (he “Comp
Kaixin Holdings Announces Receipt of Nasdaq Letter Regarding Regaining Compliance with Minimum Bid Price Requirement
07:06am, Wednesday, 13'th Nov 2024
HANGZHOU, China, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Kaixin Holdings (“Kaixin” or the “Company”) (NASDAQ: KXIN) today announced the receipt of a notification letter dated November 12, 2024 from
Fusion Fuel Receives Staff Determination Notice from Nasdaq, Submits Appeal Request
04:15pm, Tuesday, 12'th Nov 2024
DUBLIN, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Fusion Fuel Green PLC (“Fusion Fuel” or the “Company”) today announced that the Company received a letter (the “Staff Determination Notice”) from
LifeWallet Announces Reverse Stock Split to Regain Compliance with Nasdaq's Minimum Bid Price Requirement
12:00pm, Tuesday, 12'th Nov 2024
MIAMI, Nov. 12, 2024 (GLOBE NEWSWIRE) -- MSP Recovery, Inc. d/b/a LifeWallet (NASDAQ: LIFW) (“LifeWallet,” or the “Company”), a Medicare, Medicaid, commercial, and secondary payer reimbursemen
BioHarvest shares rise in Nasdaq debut
10:14am, Tuesday, 12'th Nov 2024
BioHarvest Sciences Inc. (CSE:BHSC, OTC:CNVCF) began trading on the Nasdaq Global Market on Tuesday under the ticker symbol "BHST." Shares of the company gained nearly 5% in early morning trading, rea
Mustang Bio Receives Positive Listing Determination from Nasdaq
08:30am, Tuesday, 12'th Nov 2024
WORCESTER, Mass., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang” or the “Company”) (Nasdaq: MBIO), a clinical-stage biopharmaceutical company focused on translating today's med
BioHarvest Sciences Begins Trading on the Nasdaq Global Market
08:30am, Tuesday, 12'th Nov 2024
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - November 12, 2024) - BioHarvest Sciences Inc. (NASDAQ: BHST) (CSE: BHSC) ("BioHarvest" or the "Company"), a company pioneering its p
Opus Genetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
07:59am, Tuesday, 12'th Nov 2024
FARMINGTON HILLS, Mich., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Opus Genetics, Inc. (Nasdaq: IRD), a clinical-stage ophthalmic biopharmaceutical company developing therapies to treat patients with inherite
Tech stocks hold back Nasdaq as Nvidia, Apple, Meta lag
04:59pm, Monday, 11'th Nov 2024
To get the latest market news check out finance.yahoo.com Tech stocks lagged on Monday, holding the Nasdaq Composite (^IXIC) back from the rest of the market euphoria. With the exception of (TSLA) gai
Nasdaq Announces End-of-Month Open Short Interest Positions in Nasdaq Stocks as of Settlement Date October 31, 2024
04:05pm, Monday, 11'th Nov 2024
NEW YORK, Nov. 11, 2024 (GLOBE NEWSWIRE) -- At the end of the settlement date of October 31, 2024, short interest in 3,083 Nasdaq Global MarketSM securities totaled 12,172,949,545 shares compared with
Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:05pm, Monday, 11'th Nov 2024
Brisbane, Calif., Nov. 11, 2024 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA) today announced that on November 4, 2024, the Compensation Committee granted inducement awards consisting of
Crinetics Pharmaceuticals Announces November 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:05pm, Monday, 11'th Nov 2024
SAN DIEGO, Nov. 11, 2024 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on November 10, 2024, the Compensation Committee of Crinetics' Board of Directors grant
Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
04:01pm, Monday, 11'th Nov 2024
SAN DIEGO--(BUSINESS WIRE)--Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary
